Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7
- PMID: 15723075
- DOI: 10.1038/nm1191
Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7
Abstract
Short interfering RNA (siRNA) is used in RNA interference technology to avoid non-target-related induction of type I interferon (IFN) typical for long double-stranded RNA. Here we show that in plasmacytoid dendritic cells (PDC), an immune cell subset specialized in the detection of viral nucleic acids and production of type I IFN, some siRNA sequences, independent of their GU content, are potent stimuli of IFN-alpha production. Localization of the immunostimulatory motif on the sense strand of a potent IFN-alpha-inducing siRNA allowed dissection of immunostimulation and target silencing. Injection into mice of immunostimulatory siRNA, when complexed with cationic liposomes, induced systemic immune responses in the same range as the TLR9 ligand CpG, including IFN-alpha in serum and activation of T cells and dendritic cells in spleen. Immunostimulation by siRNA was absent in TLR7-deficient mice. Thus sequence-specific TLR7-dependent immune recognition in PDC needs to be considered as an additional biological activity of siRNA, which then should be termed immunostimulatory RNA (isRNA).
Comment in
-
Sensing the danger in RNA.Nat Med. 2005 Mar;11(3):250-1. doi: 10.1038/nm0305-250. Nat Med. 2005. PMID: 15746933 No abstract available.
Similar articles
-
In vitro-generated viral double-stranded RNA in contrast to polyinosinic:polycytidylic acid induces interferon-alpha in human plasmacytoid dendritic cells.Scand J Immunol. 2006 Apr;63(4):264-74. doi: 10.1111/j.1365-3083.2006.01736.x. Scand J Immunol. 2006. PMID: 16623926
-
Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.J Leukoc Biol. 2007 Sep;82(3):497-508. doi: 10.1189/jlb.0906575. Epub 2007 Jun 12. J Leukoc Biol. 2007. PMID: 17565046
-
siRNA and isRNA: two edges of one sword.Mol Ther. 2006 Oct;14(4):463-70. doi: 10.1016/j.ymthe.2006.06.001. Epub 2006 Jul 31. Mol Ther. 2006. PMID: 16877044 Review.
-
Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7.Int Immunol. 2008 Jan;20(1):1-9. doi: 10.1093/intimm/dxm112. Epub 2007 Nov 1. Int Immunol. 2008. PMID: 17981792
-
Signalling pathways leading to IFN-alpha production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications.J Intern Med. 2009 Jan;265(1):43-57. doi: 10.1111/j.1365-2796.2008.02050.x. J Intern Med. 2009. PMID: 19093959 Review.
Cited by
-
Nanoparticles as Drug Delivery Systems of RNAi in Cancer Therapy.Molecules. 2021 Apr 19;26(8):2380. doi: 10.3390/molecules26082380. Molecules. 2021. PMID: 33921892 Free PMC article. Review.
-
Lysosomal Storage Disease-Associated Neuropathy: Targeting Stable Nucleic Acid Lipid Particle (SNALP)-Formulated siRNAs to the Brain as a Therapeutic Approach.Int J Mol Sci. 2020 Aug 10;21(16):5732. doi: 10.3390/ijms21165732. Int J Mol Sci. 2020. PMID: 32785133 Free PMC article. Review.
-
In vivo screening of modified siRNAs for non-specific antiviral effect in a small fish model: number and localization in the strands are important.Nucleic Acids Res. 2012 May;40(10):4653-65. doi: 10.1093/nar/gks033. Epub 2012 Jan 28. Nucleic Acids Res. 2012. PMID: 22287630 Free PMC article.
-
A heat-shock protein axis regulates VEGFR2 proteolysis, blood vessel development and repair.PLoS One. 2012;7(11):e48539. doi: 10.1371/journal.pone.0048539. Epub 2012 Nov 6. PLoS One. 2012. PMID: 23139789 Free PMC article.
-
Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis.Mol Ther. 2012 Mar;20(3):609-15. doi: 10.1038/mt.2011.270. Epub 2011 Dec 20. Mol Ther. 2012. PMID: 22186791 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
